InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specializes in developing and marketing cutting-edge medical devices for aesthetic procedures. Based in Yokne’am, Israel, this innovative company is..
Pharvaris N.V. (PHVS), a notable player in the biotechnology sector, is capturing investor attention with its promising focus on rare disease therapies. Headquartered in Zug, Switzerland, this late-stage biopharmaceutical company..
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a healthcare innovator making significant strides in the drug manufacturing sector, particularly within the specialty and generic drug industry. Headquartered in Dublin, Ireland, Avadel’s..
Simulations Plus, Inc. (NASDAQ: SLP) is carving a niche within the healthcare sector, particularly in the health information services industry. The company’s software solutions for drug discovery and development leverage..
SI-BONE, Inc. (NASDAQ: SIBN) stands out as a promising player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $845.26 million, this U.S.-based company..
Cronos Group Inc. (NASDAQ: CRON), a key player in the global cannabinoid market, continues to capture the attention of investors with its unique position in the healthcare sector. Despite a..
CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostic solutions for transplant patients, has recently caught the attention of investors with a potential upside of..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a notable player in the healthcare sector, specifically in biotechnology, has captured the attention of investors with its significant potential upside. As a commercial-stage biopharmaceutical..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing attention in the biotech sector with its innovative approach to tackling unmet medical needs in cancer treatment. With a market capitalization of $951.54..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) is capturing attention in the biotechnology sector with its innovative approach to gene editing. Headquartered in Cambridge, Massachusetts, Intellia is a clinical-stage company that specializes..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is attracting significant interest from investors, particularly given its compelling potential upside of 119.86%. This biopharmaceutical company, headquartered in Cambridge, Massachusetts, specializes in developing innovative..
Ardelyx, Inc. (NASDAQ: ARDX) has emerged as a notable player in the biotechnology sector, drawing investor attention with its promising drug portfolio and significant potential upside. With a current market..
CeriBell, Inc. (NASDAQ: CBLL), a cutting-edge player in the healthcare sector, is capturing attention with its innovative medical devices and a notable potential upside of 46.15%. As a company dedicated..
CorMedix Inc. (NASDAQ: CRMD), a promising player in the biotechnology sector, is capturing investor attention with its impressive growth metrics and significant potential upside. As a biopharmaceutical company focused on..
Fulgent Genetics, Inc. (FLGT), a prominent player in the healthcare sector’s diagnostics and research industry, is drawing attention from investors with a notable potential upside of 11.66%. Nestled in the..
Embecta Corp. (NASDAQ: EMBC) stands at the intersection of innovation and healthcare, offering compelling opportunities for investors focused on the medical instruments and supplies sector. With a market capitalization of..
Niagen Bioscience, Inc. (NASDAQ: NAGE), a dynamic player in the biotechnology sector, is grabbing the attention of investors with its remarkable potential upside and robust growth metrics. The company, headquartered..
Gyre Therapeutics, Inc. (NASDAQ: GYRE), a key player in the biotechnology sector, is generating notable interest among investors due to its promising drug pipeline and substantial potential for stock price..
